46488 Federal Register / Vol. 83, No. 178 / Thursday, September 13, 2018 / Notices 

182, 140 Stat. 448 (2016), and operates 

in accordance with the Federal 

Advisory Committee Act (FACA) of 

1972. The SACC supports activities 

under the Toxic Substances Control Act 

(TSCA), 15 U.S.C. 2601 et seq., the 

Pollution Prevention Act (PPA), 42 

U.S.C. 13101 et seq., and other 

applicable statutes. The SACC provides 

independent scientific advice and 

recommendations to the EPA on the 

scientific and technical aspects of risk 

assessments, methodologies, and 

pollution prevention measures and 

approaches for chemicals regulated 

under TSCA. 

The SACC is comprised of experts in: 

Toxicology; environmental risk 

assessment; exposure assessment; and 

related sciences (e.g., synthetic biology, 

pharmacology, biotechnology, 

nanotechnology, biochemistry, 

biostatistics, PBPK modeling, 

computational toxicology, 

epidemiology, environmental fate, and 

environmental engineering and 

sustainability). The SACC currently 

consists of 26 members. When needed, 

the committee will be assisted in their 

reviews by ad hoc reviewers with 

specific expertise in the topics under 

consideration. 

At this time, EPA is seeking 

nominations to create a pool of experts 

who can be available to the SACC to 

assist in reviews conducted by the 

Committee. EPA anticipates selecting 

experts from this pool, as needed, to 

assist the SACC in their review of EPA’s 

risk evaluations for the first 10 chemical 

substances addressed under the TSCA: 

Pigment Violet 29; 1,4-Dioxane, 

Asbestos; Cyclic Aliphatic Bromide 

Cluster (HBCD); 1-Bromopropane; 

Perchloroethylene; Trichloroethylene; 

Carbon Tetrachloride; Methylene 

Chloride; and n-Methylpyrolidone. 

In addition, EPA anticipates selecting 

from the pool of experts, as needed, to 

appoint SACC members to fulfill short 

term needs when a vacancy occurs on 

the Committee due to resignation or 

reasons other than expiration of a term. 

Authority: 15 U.S.C. 2625 et seq.; 5 U.S.C. 

Appendix 2 et seq. 

Dated: September 4, 2018. 

Stanley Barone, Jr., 

Acting Director, Office of Science 

Coordination and Policy. 

[FR Doc. 2018–19952 Filed 9–12–18; 8:45 am] 

BILLING CODE 6560–50–P 

FEDERAL RESERVE SYSTEM 

Change in Bank Control Notices; 

Acquisitions of Shares of a Bank or 

Bank Holding Company 

The notificants listed below have 

applied under the Change in Bank 

Control Act (12 U.S.C. 1817(j)) and 

§ 225.41 of the Board’s Regulation Y (12 

CFR 225.41) to acquire shares of a bank 

or bank holding company. The factors 

that are considered in acting on the 

notices are set forth in paragraph 7 of 

the Act (12 U.S.C. 1817(j)(7)). 

The notices are available for 

immediate inspection at the Federal 

Reserve Bank indicated. The notices 

also will be available for inspection at 

the offices of the Board of Governors. 

Interested persons may express their 

views in writing to the Reserve Bank 

indicated for that notice or to the offices 

of the Board of Governors. Comments 

must be received not later than October 

1, 2018. 

A. Federal Reserve Bank of Dallas 

(Robert L. Triplett III, Senior Vice 

President) 2200 North Pearl Street, 

Dallas, Texas 75201–2272: 

1. Davron Santa Fe Properties, Ltd., 

Wolfforth, Texas, RKB Family 

Investments LR, LP, DF Family 

Investments LR, LP, Ronnie K. Bilbo, 

and David L. Foster, all of Lubbock, 

Texas; as a group acting in concert, to 

acquire voting shares of Peoples 

Bancorp, Inc., and indirectly acquire 

shares of Peoples Bank, both of 

Lubbock, Texas. 

Board of Governors of the Federal Reserve 

System, September 10, 2018. 

Yao-Chin Chao, 

Assistant Secretary of the Board. 

[FR Doc. 2018–19943 Filed 9–12–18; 8:45 am] 

BILLING CODE 6210–01–P 

FEDERAL RESERVE SYSTEM 

Formations of, Acquisitions by, and 

Mergers of Bank Holding Companies 

The companies listed in this notice 

have applied to the Board for approval, 

pursuant to the Bank Holding Company 

Act of 1956 (12 U.S.C. 1841 et seq.) 

(BHC Act), Regulation Y (12 CFR part 

225), and all other applicable statutes 

and regulations to become a bank 

holding company and/or to acquire the 

assets or the ownership of, control of, or 

the power to vote shares of a bank or 

bank holding company and all of the 

banks and nonbanking companies 

owned by the bank holding company, 

including the companies listed below. 

The applications listed below, as well 

as other related filings required by the 

Board, are available for immediate 

inspection at the Federal Reserve Bank 

indicated. The applications will also be 

available for inspection at the offices of 

the Board of Governors. Interested 

persons may express their views in 

writing on the standards enumerated in 

the BHC Act (12 U.S.C. 1842(c)). If the 

proposal also involves the acquisition of 

a nonbanking company, the review also 

includes whether the acquisition of the 

nonbanking company complies with the 

standards in section 4 of the BHC Act 

(12 U.S.C. 1843). Unless otherwise 

noted, nonbanking activities will be 

conducted throughout the United States. 

Unless otherwise noted, comments 

regarding each of these applications 

must be received at the Reserve Bank 

indicated or the offices of the Board of 

Governors not later than October 11, 

2018. 

A. Federal Reserve Bank of Chicago 

(Colette A. Fried, Assistant Vice 

President) 230 South LaSalle Street, 

Chicago, Illinois 60690–1414: 

1. First Busey Corporation, 

Champaign, Illinois; to acquire voting 

shares of The Banc Ed Corp., 

Edwardsville, Illinois, and thereby 

indirectly acquire The Bank of 

Edwardsville, Edwardsville, Illinois. 

Board of Governors of the Federal Reserve 

System, September 10, 2018. 

Yao-Chin Chao, 

Assistant Secretary of the Board. 

[FR Doc. 2018–19942 Filed 9–12–18; 8:45 am] 

BILLING CODE 6210–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–18–0212; Docket No. CDC–2018– 

0084] 

Proposed Data Collection Submitted 

for Public Comment and 

Recommendations 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice with comment period. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), as part of 

its continuing effort to reduce public 

burden and maximize the utility of 

government information, invites the 

general public and other Federal 

agencies the opportunity to comment on 

a proposed and/or continuing 

information collection, as required by 

the Paperwork Reduction Act of 1995. 

This notice invites comment on a 


daltland on DSKBBV9HB2PROD with NOTICES
Federal Register / Vol. 83, No. 178 / Thursday, September 13, 2018 / Notices 46489 

proposed information collection project 

titled National Hospital Care Survey, an 

electronic data collection that describes 

hospital care utilization in the U.S. 

DATES: CDC must receive written 

comments on or before November 13, 

2018. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2018– 

0084 by any of the following methods: 

• Federal eRulemaking Portal: 

Regulations.gov. Follow the instructions 

for submitting comments. 

• Mail: Jeffrey M. Zirger, Information 

Collection Review Office, Centers for 

Disease Control and Prevention, 1600 

Clifton Road NE, MS–D74, Atlanta, 

Georgia 30329. 

Instructions: All submissions received 

must include the agency name and 

Docket Number. CDC will post, without 

change, all relevant comments to 

Regulations.gov. 

Please note: Submit all comments 

through the Federal eRulemaking portal 

(regulations.gov) or by U.S. mail to the 

address listed above. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the information collection plan and 

instruments, contact Jeffrey M. Zirger, 

Information Collection Review Office, 

Centers for Disease Control and 

Prevention, 1600 Clifton Road NE, MS– 

D74, Atlanta, Georgia 30329; phone: 

404–639–7570; Email: omb@cdc.gov. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), Federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. In addition, the PRA also 

requires Federal agencies to provide a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each new 

proposed collection, each proposed 

extension of existing collection of 

information, and each reinstatement of 

previously approved information 

collection before submitting the 

collection to the OMB for approval. To 

comply with this requirement, we are 

publishing this notice of a proposed 

data collection as described below. 

The OMB is particularly interested in 

comments that will help: 

1. Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

2. Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

3. Enhance the quality, utility, and 

clarity of the information to be 

collected; and 

4. Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submissions 

of responses. 

5. Assess information collection costs. 

Proposed Project 

The National Hospital Care Survey 

(NHCS) (OMB Control Number 0920– 

0212; Exp. Date 01/31/2019)— 

Revision—National Center for Health 

Statistics (NCHS), Centers for Disease 

Control and Prevention (CDC). 

Background and Brief Description 

Section 306 of the Public Health 

Service (PHS) Act (42 U.S.C. 242k), as 

amended, authorizes that the Secretary 

of Health and Human Services (DHHS), 

acting through NCHS, shall collect 

statistics on the extent and nature of 

illness and disability of the population 

of the United States. This three-year 

clearance request for NHCS includes the 

collection of all inpatient and 

ambulatory Uniform Bill-04 (UB–04) 

claims data or electronic health record 

(EHR) data as well as the collection of 

hospital-level information via a 

questionnaire from a sample of 598 

hospitals. 

The NHCS collects data on patient 

care in hospital-based settings to 

describe patterns of health care delivery 

and utilization in the United States. 

NHCS hospital-based settings include 

inpatient, emergency (EDs), and 

outpatient departments (OPDs). The 

survey will provide hospital utilization 

statistics for the Nation. In addition, the 

NHCS will also be able to monitor 

national trends in substance use-related 

ED visits including opioid visits. 

NHCS consists of a nationally 

representative sample of 598 hospitals. 

These hospitals are currently being 

recruited, and participating hospitals 

are submitting all of their inpatient and 

ambulatory care patient data in the form 

of electronic UB–04 administrative 

claims or EHR data. Currently, hospitallevel data are collected through a 

questionnaire administered via a web 

portal. 

This revision seeks approval to 

continue voluntary recruitment of 

hospitals in the sample for the NHCS; 

continue the collection of hospital-level 

data through an initial intake 

questionnaire and an Annual Hospital 

Interview for all sampled hospitals; 

continue the collection of electronic 

data on inpatient discharges as well as 

emergency department (ED) and 

outpatient department (OPD) visits 

through the collection of EHR data, UB– 

04 claims, or a state file; continue 

collection of substance-involved ED 

visit data through the ED component; 

eliminate medical record abstraction of 

a sample of ED and OPD visits as part 

of the design of the survey; and 

postpone frame development for free 

standing ambulatory care facilities. 

NHCS collects data items at the 

hospital, patient, inpatient discharge, 

and visit levels. Hospital-level data 

items include ownership, number of 

staffed beds, hospital service type, and 

EHR adoption. Patient-level data items 

are collected from electronic data and 

include basic demographic information, 

personal identifiers, name, address, 

social security number (if available), 

and medical record number (if 

available). Discharge-level data are 

collected through the UB–04 claims or 

EHR data and include admission and 

discharge dates, diagnoses, diagnostic 

services, and surgical and non-surgical 

procedures. Visit-level data are 

collected through EHR data and include 

reason for visit, diagnosis, procedures, 

medications, substances involved, and 

patient disposition. 

NHCS data have distinct advantages. 

Through the collection of personal 

identifiers, NHCS data can be linked to 

outside datasets such as the National 

Death Index (OMB No. 0920–0215, Exp. 

Date 12/31/2019) to calculate postdischarge mortality. Additionally, 

NHCS offers unique opportunities to 

study opioid-involved health outcomes, 

such as repeat hospital encounters for 

opioid use and opioid-related mortality 

rates. 

NHCS users include, but are not 

limited to, CDC, Congressional Research 

Office, Office of the Assistant Secretary 

for Planning and Evaluation (ASPE), 

National Institutes of Health, American 

Health Care Association, Centers for 

Medicare & Medicaid Services (CMS), 

SAMHSA, Bureau of the Census, Office 

of National Drug Control Policy, state 

and local governments, and nonprofit 

organizations. Other users of these data 

include universities, research 

organizations, many in the private 

sector, foundations, and a variety of 

users in the media. 

Data collected through NHCS are 

essential for evaluating the health status 

of the population, for the planning of 

programs and policy to improve health 

care delivery systems of the Nation, for 

studying morbidity trends, and for 


daltland on DSKBBV9HB2PROD with NOTICES
46490 Federal Register / Vol. 83, No. 178 / Thursday, September 13, 2018 / Notices 

research activities in the health field. 

Historically, data have been used 

extensively in the development and 

monitoring of goals for the Year 2000, 

2010, and 2020 Healthy People 

Objectives. 

There is no cost to respondents other 

than their time to participate. The total 

annualized burden is 7,080 hours. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondents Form name Number of 

respondents 

Number of 

responses 

per 

respondent 

Average 

burden per 

response 

(in hours) 

Total 

burden 

(in hours) 

Hospital Director of Health Information Management (DHIM) or Director of Health Information Technology (DHIT).Initial Hospital Intake Questionnaire 150 1 1 150 

Hospital Chief Executive Officer 

(CEO)/Chief Financial Officer 

(CFO).

Recruitment Survey Presentation .... 150 1 1 150 

Hospital DHIM or DHIT ..................... Prepare and transmit UB–04 or 

State File for Inpatient and Ambulatory.

399 12 1 4,788 

Hospital DHIM or DHIT ..................... Prepare and transmit EHR for Inpatient and Ambulatory.199 4 1 796 

Hospital CEO/CFO ............................ Annual Hospital Interview ................ 598 1 2 1,196 

Total ........................................... ........................................................... ........................ ........................ ........................ 7,080 

Jeffrey M. Zirger, 

Acting Chief, Information Collection Review 

Office, Office of Scientific Integrity, Office 

of the Associate Director for Science, Office 

of the Director, Centers for Disease Control 

and Prevention. 

[FR Doc. 2018–19901 Filed 9–12–18; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[30Day–18–0666] 

Agency Forms Undergoing Paperwork 

Reduction Act Review 

In accordance with the Paperwork 

Reduction Act of 1995, the Centers for 

Disease Control and Prevention (CDC) 

has submitted the information 

collection request titled National 

Healthcare Safety Network to the Office 

of Management and Budget (OMB) for 

review and approval. CDC previously 

published a ‘‘Proposed Data Collection 

Submitted for Public Comment and 

Recommendations’’ notice on May 11, 

2018 to obtain comments from the 

public and affected agencies. CDC 

received one comment related to the 

previous notice. This notice serves to 

allow an additional 30 days for public 

and affected agency comments. 

CDC will accept all comments for this 

proposed information collection project. 

The Office of Management and Budget 

is particularly interested in comments 

that: 

(a) Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

(b) Evaluate the accuracy of the 

agencies estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

(c) Enhance the quality, utility, and 

clarity of the information to be 

collected; 

(d) Minimize the burden of the 

collection of information on those who 

are to respond, including, through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submission of 

responses; and 

(e) Assess information collection 

costs. 

To request additional information on 

the proposed project or to obtain a copy 

of the information collection plan and 

instruments, call (404) 639–7570 or 

send an email to omb@cdc.gov. Direct 

written comments and/or suggestions 

regarding the items contained in this 

notice to the Attention: CDC Desk 

Officer, Office of Management and 

Budget, 725 17th Street, NW, 

Washington, DC 20503 or by fax to (202) 

395–5806. Provide written comments 

within 30 days of notice publication. 

Proposed Project 

National Healthcare Safety Network 

(0920–0666, Expiration Date 1/31/ 

2021)—Revision—National Center for 

Emerging and Zoonotic Infectious 

Diseases (NCEZID), Centers for Disease 

Control and Prevention (CDC). 

Background and Brief Description 

NHSN is a public health surveillance 

system that collects, analyzes, reports, 

and makes available data for 

monitoring, measuring, and responding 

to healthcare associated infections 

(HAIs), antimicrobial use and resistance, 

blood transfusion safety events, and the 

extent to which healthcare facilities 

adhere to infection prevention practices 

and antimicrobial stewardship. 

Specifically, resulting data estimates the 

magnitude of Healthcare Associated 

Infections (HAI), monitor HAI trends, 

and facilitate inter-facility and intrafacility comparisons with risk-adjusted 

data used for local quality improvement 

activities. The data will be used to 

detect changes in the epidemiology of 

adverse events resulting from new and 

current medical therapies and changing 

risks. The NHSN currently consists of 

six components: Patient Safety, 

Healthcare Personnel Safety, 

Biovigilance, Long-Term Care Facility 

(LTCF), Outpatient Procedure 

Component, and Dialysis. 

Changes were made to 34 data 

collection facility surveys with this 

revision ICR. CDC revised three annual 

facility surveys for the Patient Safety 

component for Hospitals, Long-Term 

Acute Care Facilities, and Inpatient 

Rehabilitation Facilities. CDC’s 

revisions clarify the reporting 

requirements for the data collected on 

fungal testing, facility locations, and 

laboratory testing locations. 

Additionally, corresponding response 


daltland on DSKBBV9HB2PROD with NOTICES